Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs FibroBiologics, Inc. Common Stock (FBLG)

A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and FibroBiologics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cadrenal Therapeutics, Inc. Common Stock logo
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$3M
$0.91HealthcareDelayed quote: Oct 6, 2026, 12:07 PM EDT
FibroBiologics, Inc. Common Stock logo
FBLG
FibroBiologics, Inc. Common Stock
$3M
$1.20HealthcareDelayed quote: Oct 6, 2026, 12:04 PM EDT

Total return — CVKD vs FBLG

growth of $100 · dividends reinvested · last 3y
CVKD -96.5% (-67.4%/yr)FBLG -99.8% (-87.3%/yr)CVKD compounded faster over this window
Log scale — wide-divergence pair
0110100Start $10020252026$3$0
CVKD FBLG

CVKD vs FBLG: by the numbers

  • •CVKD is the larger company ($3M vs $3M market cap).

Metrics side by side

Valuation

MetricCVKDFBLG
P/B ratio0.800.54

Profitability

MetricCVKDFBLG
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-282.13%-391.26%
ROIC-284.81%-286.46%

Go deeper

Full CVKD analysisFull FBLG analysisInteractive comparison tool

Dig into the metrics

Cadrenal Therapeutics, Inc. Common Stock ROEFibroBiologics, Inc. Common Stock ROECadrenal Therapeutics, Inc. Common Stock operating marginFibroBiologics, Inc. Common Stock operating marginCadrenal Therapeutics, Inc. Common Stock revenue growthFibroBiologics, Inc. Common Stock revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flowFibroBiologics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.